Merck KGaA to acquire SpringWorks Therapeutics for $3.9B

The latest stories trending on MedCity News.

Editor's Pick

Top Story Merck KGaA's Rare Tumor Strategy Takes Shape With $3.9B SpringWorks Acquisition SpringWorks Therapeutics brings to Merck KGaA two FDA-approved drugs, both currently under regulatory review in Europe. Beyond their initial applications in rare tumors, these small molecules are also being studied as monotherapies and as part of combinations treatments for certain cancers. Sponsored Take the 2025 Benefit Consultant Sentiment Index Survey Presented by MedCity News and Quantum Health Consultants! Help define what's next in healthcare benefits.  Take our short survey and shape the future of healthcare benefits by sharing your insights and you'll receive a $20 Amazon gift card!* *In order to receive a gift card, participants must meet survey qualifications (we are looking for experienced consultants who advise self-insured employers on healthcare benefits) and provide a valid business email address. Once the survey is closed, certificates will be issued. Aman Shah, Vice President of New VNS Health will be Speaking at INVEST 2025 Aman will be part of the panel, "Investor Perspective: What's Hot What's Not". Hear from a panel of investment leaders from different healthcare industry sectors about the current investment climate. Learn about their strategic priorities and get advice on how startup founders can best succeed in fundraising. Register Now

Featured News

Webinar: How Fintech Can Accelerate Growth for Early-Stage Life Science Companies [Sponsored] Sign up today and and join us on May 8th where we'll explore how a banking platform approach could be a resource for the needs of entrepreneurs across biotech, diagnostics, and other life science companies. 3 Things Hospitals Must Remember to Drive Better Quality & Safety To improve patient outcomes, hospitals must enable collaboration across disciplines, engage frontline staff in decision making, and make changes based on patient feedback, according to a panel of health system executives. Hinge Health Launches MSK Collaboration with Cigna Healthcare Cigna's self-insured clients now have the option to offer the Hinge Health platform to its employees. Through the platform, patients gain virtual access to physical therapists, health coaches, real-time guidance and a wearable pain relief device. Value-Based Care Gets Real The mandatory CMS TEAM program begins next year. Are you ready? As hospitals consider their options for addressing the mandate, here are some actions to consider. It's Time for Medical Malpractice Insurance to Emerge from the Stone Age The status quo for medical malpractice insurance is no longer good enough. While we must always prioritize the need for accountability when it comes to medical malpractice, we must also consider how challenges like increased premiums, rising costs and new risks are impacting providers and consequentially patients.

Video   What Should Employers Be Thinking About as They Develop Their Pharmacy Benefit Strategy? For Josh Golden, Capital Rx's senior vice president of strategy, it boils down to one question employers need to be asking themselves: Does my pharmacy benefit manager make more money when I spend more money? Most PBM profit models are tied directly to the price and volume of drugs, he noted.

Sponsored The Top 6 Best Analytics Tools for Health Care Revenue in 2025 Presented by Millennia Finding the best analytics tools for health care revenue management can revolutionize operational processes. Compare the leading software options to discover helpful team resources. Learn More

Resources

MedCity Pivot: What if Pancreatic Cancer Became a Chronic Disease? Ben Zeskind, co-founder, president and CEO of Immuneering, is attempting a new approach to treat certain types of cancers. If it works, there will be a vast improvement in the quality of life of cancer patients. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe